Expanded criteria for liver transplantation in patients with hepatocellular carcinoma

被引:16
作者
Yao, Francis Y. [1 ]
机构
[1] Univ Calif San Francisco, Dept Clin Med & Surg, San Francisco, CA 94143 USA
关键词
hepatocellular carcinoma; Milan criteria; orthotopic liver transplantation; University of California San; Francisco criteria;
D O I
10.1111/j.1872-034X.2007.00195.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Following the seminal publication by the group from Milan, Italy using a restrictive set of criteria for orthotopic liver transplantation in patients with hepatocellular carcinoma to limit the risk for tumor recurrence, excellent 5-year patient survival of greater than 70% after liver transplantation has been reported from many centers using criteria similar to or slightly exceeding the Milan criteria (single lesion of >= 5 cm, or 2-3 lesions of : 3 cm). The growing experience and success of orthotopic liver transplantation for HCC have also fueled controversies related to expansion of conventional criteria for cadaveric or living-donor liver transplantation based on tumor size and number. The limitations of imaging studies, exemplified by tumor under-staging in up to 25% of patients, have been a major concern for liberalizing the current criteria for liver transplantation. The University of California, San Francisco criteria (single lesion of <= 6.5 cm, or 2-3 lesions of <= 4.5 cm with a total tumor diameter ! 8 cm) have been independently tested in several studies, and undergone prospective evaluation based on preoperative imaging. This article provides an in-depth review of published data on expansion of current criteria for liver transplantation.
引用
收藏
页码:S267 / S274
页数:8
相关论文
共 31 条
[1]   Liver transplantation for hepatocellular carcinoma [J].
Befeler, AS ;
Hayashi, PH ;
Di Bisceglie, AM .
GASTROENTEROLOGY, 2005, 128 (06) :1752-1764
[2]   Should we expand the criteria for liver transplantation for hepatocellular carcinoma - Yes, of course! [J].
Broelsch, CE ;
Frilling, A ;
Malago, M .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :569-573
[3]   Liver transplantation for hepatocellular carcinoma: foucault pendulum versus evidence-based decision [J].
Bruix, J ;
Fuster, J ;
Llovet, JM .
LIVER TRANSPLANTATION, 2003, 9 (07) :700-702
[4]   Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma [J].
Decaens, T ;
Roudot-Thoraval, F ;
Bresson-Hadni, S ;
Meyer, C ;
Gugenheim, J ;
Durand, F ;
Bernard, PH ;
Boillot, O ;
Boudjema, K ;
Calmus, Y ;
Hardwigsen, J ;
Ducerf, C ;
Pageaux, GP ;
Dharancy, S ;
Chazouilleres, O ;
Dhumeaux, D ;
Cherqui, D ;
Duvoux, C .
LIVER TRANSPLANTATION, 2005, 11 (07) :767-775
[5]  
Decaens T, 2004, HEPATOLOGY, V40, p550A
[6]  
Edmondson H, 1954, CANCER, V1, P462
[7]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[8]  
Eng Sue C, 2002, Gastroenterology, V122, P579, DOI 10.1016/S0016-5085(02)80327-4
[9]   Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149
[10]   Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma [J].
Herrero, JI ;
Sangro, B ;
Quiroga, J ;
Pardo, F ;
Herraiz, M ;
Cienfuegos, JA ;
Prieto, J .
LIVER TRANSPLANTATION, 2001, 7 (07) :631-636